Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07504575

Effect of PRP in Donor Semen During Cryoprervation

Sperm cryopreservation allows the preservation of sperm biological function for long periods of time for later use in assisted reproductive techniques (ART). However, the freezing and thawing process causes structural and functional damage to sperm, leading to decreased motility and vitality, a loss of plasma membrane integrity and even DNA damage.

In recent years, various strategies have been studied to protect sperm from cryodamage, including the optimization of freezing processes, the design of freezing devices, and improved freezing media.

One possible measure to mitigate the cryodamage suffered by sperm is the addition of PRP, or platelet-rich plasma, to the freezing medium. In previous studies, PRP components have been shown to have positive effects on semen quality, improving motility, viability, and plasma membrane integrity after cryopreservation. In light of these positive results, this study will evaluate the possibility of incorporating PRP into sperm cryopreservation media and its potential future benefits for patients and clinical outcomes. To this end, each semen sample after a previous spermiogram will be aliquoted, and 0%, 1%, 2%, and 5% PRP will be added to the cryopreservation medium according to the sperm group to which the belong. A spermiogram will be performed after cryopreservation to assess various semen quality parameters, including sperm count, motility, morphology, vitality, and chromatin dispersion. The data must be processed through statistical analysis to obtain results that allow determining, primarily, whether there is a beneficial effect on sperm quality after sperm motility and sperm during cryopreservation with the addition of PRP.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–35 year

Sex eligibility

Male

Study type

Observational

Primary location

About this study

The main objective of this study will be to detect whether there is a significant difference in progressive mobility between the control group and the cryopreserved samples with 5% autologous PRP.

The secondary objectives will be as follows:

Detect significant differences in progressive mobility between the control group and the cryopreserved samples with autologous PRP at concentrations of 1% or 2%; Determine if there are significant differences in the values of the semen quality parameters according to the categorical concentration of PRP used in cryopreservation.; Determine if there is a correlation between the numerical concentration of PRP and the semen quality parameters; Check if the platelet count, that is, the concentration of platelets present in the autologous plasma which has a higher concentration of platelets than the original sample, is correlated with the semen parameters analyzed post-thawing.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age from 18 to 35 years

Concentration higher than 50 million progressively motile sperm.

Morphology: more than 4% normal sperm shapes.

Exclusion criteria

Presence of personal or hereditary pathology.

Presence of psychological or behavioral disorder.

Semen parameters below those indicated in the inclusion criteria.

Treatment and study plan

Primary outcomes

  1. Progressive sperm motility after thawing

    Time frame: Immediately after thawing of the semen samples.

    Percentage of progressively motile spermatozoa in semen samples after cryopreservation, comparing control samples with samples cryopreserved with 5% autologous platelet-rich plasma (PRP).

Study contacts

Contact information is provided by the study sponsor or research team.

Elena Sellés, PhD

CONTACT

[email protected]

+34 966012490 ext. 13503

Sponsors and collaborators

Lead sponsor

Instituto Valenciano de Infertilidad, IVI Alicante

Other

Registry information

Official study title

Effect of Platelet-rich Plasma (PRP) on the Quality of Donor Semen During Cryopreservation

Acronym: PRP

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Apr 1, 2026
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.